drugset / Trial / NCT02046304

PP-Gemcitabine & External Beam Radiation-Sarcomas

NCT02046304 ↗

NaSingle-groupOpen-labelTreatment

Summary

The goal of this clinical research study is to find the highest safe dose of gemcitabine that can be given with radiotherapy before surgery to treat sarcoma. This study will also look at how well this treatment controls sarcoma.

Timeline

Start
2001-12
Primary completion
2015-03
Completion
2015-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Gemcitabine Small molecule 400 mg/m2 Intravenous

Indications